All In MedTech

Device Trial Radar · NCT01601496

Evaluation of FUSION™ Vascular Graft for Above Knee Targets

Study of PERipheral Bypass GraFting: ProspECTive Evaluation of FUSION™ Vascular Graft for Above Knee Targets(PERFECTION)

Last checked: Nov 20, 2026Latest source record: Oct 14, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

117

Actual

Start

Oct 26, 2009

Primary completion

Jul 24, 2013

Study completion Jul 24, 2013

Sponsor

Lead sponsor
Maquet CardiovascularNot on our public-company list
Sponsor type
Industry
First posted
May 18, 2012

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the post-market study was to evaluate the safety and performance of the FUSION Vascular Graft.

Conditions

  • Peripheral Arterial Occlusive Disease (PAOD)

Interventions

  • FUSION Vascular GraftDevice

    All subjects who received the FUSION Vascular Graft at the baseline implant procedure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Participants With Primary Graft Patency at 12 MonthsTime frame: 12 Months

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • Wilhelminenspital Vienna

    Vienna, Austria

  • Klinikum Darmstadt

    Darmstadt, Germany

  • Universitätsklinikum Frankfurt

    Frankfurt am Main, Germany

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.